On March 7, Gelonghui Pharmaceutical (603811.SH) announced that as of the disclosure date of this announcement, the controlling shareholders' concerted actions increased their holdings by a total of 3,424,722 shares, accounting for 1.05% of the company's total share capital.
诚意药业(603811.SH)：控股股东之一致行动人累计增持1.05%股份
Sincerity Pharmaceutical (603811.SH): The controlling shareholders' concerted actions increased their total shareholding by 1.05%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.